Location: San Francisco, CA
CIK: 0001802967 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 12, 2025
Total Value: $136M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MDGL | Madrigal Pharmaceuticals, Inc. | 112,785 | $34.13M | 25.0% | $130.16 | +128.9% | Common Stock | 558868105 |
| TWST | Twist Bioscience Corporation | 828,815 | $30.49M | 22.4% | $23.40 | +47.6% | Common Stock | 90184D100 |
| TSLA | Tesla, Inc. | 86,250 | $27.4M | 20.1% | $212.32 | +41.9% | Common Stock | 88160R101 |
| OUST | Ouster, Inc. | 1,125,316 | $27.29M | 20.0% | $5.54 | +119.7% | Common Stock | 68989M202 |
| H | Hyatt Hotels Corporation | 70,000 | $9.775M | 7.2% | $76.75 | +62.1% | Class B Common Stock | 448579102 |
| MASS | 908 Devices Inc. | 568,981 | $4.057M | 3.0% | $58.41 | -90.5% | Common Stock | 65443P102 |
| WRBY | Warby Parker Inc. | 134,473 | $2.949M | 2.2% | $53.77 | -65.6% | Class A Common Stock | 93403J106 |
| SONDQ | Sonder Holdings Inc. | 80,188 | $217K | 0.2% | $9.74 | -79.2% | Class A Common Stock | 83542D300 |
| DNA | Ginkgo Bioworks Holdings, Inc. | 5,683 | $63,934 | 0.0% | $10.02 | -22.7% | Class A Common Stock | 37611X209 |